Home Featured Page 39

Featured

Latest

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy

Why Ketamine Is Changing Psychiatry

Trump’s Psychedelics Executive Order: Reactions From Across the Field and Beyond

Neeka Levy and Zach Skiles – Healing Ukraine Trauma

Ketamine on the Edge: Mindbloom’s At-Home Injections Spark Debate; UK Eyes...

Pα+ Psychedelic Bulletin #187: NYT Article Reignites MDMA Rejection Blame Game;...

How Psychedelics Impact the Mind: Mysticism, Mental Health, and the Future...

GH Research Reports Strong Phase 2b Results for 5-MeO-DMT in Treatment-Resistant...

2025’s Psychedelic Policy Surge: A State-by-State, Bill-by-Bill Analysis

The Psychedelic News Feed: September 2, 2024 – December 29, 2024

Psychedelic Drug Development Pipeline Updates (Q1’25)

Q1’25 Psychedelic Drug Development Pipeline: Bullseye Chart

How Do You Find the Right Facilitator? The Art of Matchmaking...

EDITOR PICKS

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy

Why Ketamine Is Changing Psychiatry

Trump’s Psychedelics Executive Order: Reactions From Across the Field and Beyond

Neeka Levy and Zach Skiles – Healing Ukraine Trauma

Ketamine on the Edge: Mindbloom’s At-Home Injections Spark Debate; UK Eyes...

Pα+ Psychedelic Bulletin #187: NYT Article Reignites MDMA Rejection Blame Game;...

How Psychedelics Impact the Mind: Mysticism, Mental Health, and the Future...

GH Research Reports Strong Phase 2b Results for 5-MeO-DMT in Treatment-Resistant...

2025’s Psychedelic Policy Surge: A State-by-State, Bill-by-Bill Analysis

The Psychedelic News Feed: September 2, 2024 – December 29, 2024

Psychedelic Drug Development Pipeline Updates (Q1’25)

Q1’25 Psychedelic Drug Development Pipeline: Bullseye Chart

How Do You Find the Right Facilitator? The Art of Matchmaking...

EDITOR PICKS

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY